KRT18 and COVID-19: Additionally, SARS-CoV-2 neuroinvasion and neurodissemination specifically makes the K18-hACE2 model invariably and prematurely fatal and, thus, limits its use for studying virus-specific immune responses, pulmonary repair mechanisms, and viral long-term effects (i.e., post-acute sequela of COVID-19 [long COVID-19]).